Pharmaceutical Validation Articles from NIR news
Volume 17 Issue 5 Pages 10–14 (2006)
doi: 10.1255/nirn.905 Implementation of near infrared and
Raman spectroscopy for tablet composition and relative density analysis for a four-component system Steven M. Short, Robert P. Cogdill and Carl A.
Anderson Duquesne University, Duquesne Center for Pharmaceutical Technology, 600 Forbes Ave, Pittsburgh, PA 15282, USA
Volume 17 Issue 2 Pages 4–6 (2006)
doi: 10.1255/nirn.878 A theoretical framework for real time
release with NIR and chemometrics Erik Skibsted,a,b Johan Westerhuis,a Age Smildea,c and D.T.
Witted aCMC Development, Novo Nordisk A/S, DK-2760 Maaloev, Denmark. E-mail: ersk@novonordisk.com bBiosystems
Data Analysis, Faculty of Science, University of Amsterdam, Nieuwe Achtergracht 166, 1018 WV, The Netherlands cTNO Quality of Life, Utrechtseweg 48,
3700 AJ Zeist, The Netherlands dQA/ALC-A, N.V. Organon, Molenstraat 10, PO Box 20, 5340 BH Oss, The Netherlands
Volume 16 Issue 7 Pages 23–26 (2005)
doi: 10.1255/nirn.858 Near infrared spectroscopy in the
pharmaceutical industry Robert P. Cogdill and James K. Drennen, III Duquesne University, Center for Pharmaceutical Technology, Pittsburgh, PA,
USA
Volume 16 Issue 5 Pages 15–15 (2005)
doi: 10.1255/nirn.839 Current thoughts on the PAT initiative. James K. Drennen, III Duquesne University Center for Pharmeceutical technology, Pittsburgh, PA 15282, USA
Volume 16 Issue 4 Pages 6–15 (2005)
doi: 10.1255/nirn.826 A prevention based strategy for quality
control using PAT Philip Lunneya,b and James K. Drennen, III aDuquesne University, Center for Pharmaceutical Technology,
Pittsburgh, PA, USA
Volume 16 Issue 3 Pages 7–8 (2005)
doi: 10.1255/nirn.817 Statistical experimental design for PAT
method development Carl A. Anderson, Robert P. Cogdill and James K. Drennen, III Duquesne University Center for Pharmaceutical Technology,
Pittsburgh, PA, Duquesne University, USA
Volume 16 Issue 2 Pages 14–15 (2005)
doi: 10.1255/nirn.813 Efficient NIR calibrations utilising pure
component projection. Carl A. Anderson and Robert P. Cogdill Duquesne University Center for Pharmaceutical Technology, Pittsburgh, PA,, USA
Volume 15 Issue 6 Pages 13–15 (2004)
doi: 10.1255/nirn.796 Calibration transfer in pharmaceutical
near infrared spectroscopy Mark R. Smith Centre for Pharmaceutical Analysis, The School of Pharmacy, University of London, 29/39 Brunswick Square,
London WC1N 1AX, UK
Volume 15 Issue 5 Pages 12–13 (2004)
doi: 10.1255/nirn.787 Risk analysis for near infrared method
development. Robert P. Cogdill, Carl A. Anderson and James K. Drennen, III Duquesne University Center for Pharmaceutical Technology, Pittsburgh,
PA 15282, USA
Volume 15 Issue 4 Pages 9–10 (2004)
doi: 10.1255/nirn.777 Critical concerns for implementing
Process Analytical Technologies in the pharmaceutical industry James K. Drennen, Carl A. Anderson and Robert P. Cogdill Duquesne University Center
for Pharmaceutical Technology, Pittsburgh, PA 15282, USA, E-mail: drennen@duq.edu
Volume 15 Issue 3 Pages 8–9 (2004)
doi: 10.1255/nirn.767 The dissolution profile of USP non-
disintegrating calibrator tablets using near infrared spectroscopy Randall J. Voytilla andJames K. Drennen Duquesne University Center for Pharceutical
Technology, Pittsburgh, PA 15282, USA, E-mail: drennen@duq.edu
Volume 15 Issue 2 Pages 9–11 (2004)
doi: 10.1255/nirn.758 PAT methods provide process
understanding Arwa S. El-Hagrasy and James K. Drennen Duquesne University Center for Pharmaceutical Technology, Pittsburgh, PA 15282, USA. E-
mail: drennen@duq.edu
Volume 15 Issue 1 Pages 16–16 (2004)
doi: 10.1255/nirn.754 New ASTM Activity on Pharmaceutical
Application of Process Analytical Technology Jim Drennen Duquesne University Center for Pharceutical Technology, Pittsburgh, PA 15282, USA, E-
mail: drennen@duq.edu
Volume 14 Issue 6 Pages 7–8 (2003)
doi: 10.1255/nirn.741 Pharmaceutical Validation. Near
infrared spectroscopy for determining the hardness of roller compacted briquettes Vishal Bijlani, Carl Anderson, Christianah Adeyeye and Jim
Drennen Duquesne University Center for Pharceutical Technology, Pittsburgh, PA 15282, USA, E-mail: drennen@duq.edu
Volume 14 Issue 5 Pages 14–15 (2003)
doi: 10.1255/nirn.736 Pharmaceutical Validation. Calibration
transfer: a critical component of analytical method validation Jim Drennen Duquesne University Center for Pharceutical Technology, Pittsburgh, PA
15282, USA, E-mail: drennen@duq.edu
Volume 14 Issue 4 Pages 14–15 (2003)
doi: 10.1255/nirn.728 Pharmaceutical Validation. PASG
NIR Sub-Group update Neville Broad Chairman, Pharmaceutical Analytical Sciences Group, NIR Sub-Group
Volume 14 Issue 3 Pages 14–15 (2003)
doi: 10.1255/nirn.720 Comparability protocols: chemistry,
manufacturing and controls information Jim Drennen and Carl Andersen Center for Pharmaceutical Technology, Duquesne University, USA
Volume 14 Issue 2 Pages 22–24 (2003)
doi: 10.1255/nirn.711 In situ spectroscopic cleaning
validation Aaron A. Urbas and Robert A. Lodder College of Pharmacy and Department of Chemistry, University of Kentucky, Lexington, KY 40536-0082,
USA. E-mail: lodder@uky.edu
Volume 13 Issue 5 Pages 8–14 (2002)
doi: 10.1255/nirn.680 Pharmaceutical Validation. Near
infrared spectroscopy for monitoring the hardness of roller compacted ribbons Vishal J. Bijlani, Miriam Delgado-Lopez, Christianah Moji Adeyeye and James K.
Drennen III Graduate School of Pharmaceutical Sciences, Duquesne University, Pittsburgh, PA 15282, USA
Volume 13 Issue 4 Pages 8–9 (2002)
doi: 10.1255/nirn.669 Pharmaceutical Validation. Non-
destructive tablet hardness testing: the effect of moisture on tablet hardness prediction James K. Drennen and Randall J. Voytilla Duquesne University,
Graduate School of Pharmaceutical Sciences, Pittsburgh, PA 15282, USA. E-mail: drennen@duq.edu
Volume 13 Issue 3 Pages 12–14 (2002)
doi: 10.1255/nirn.665 Pharmaceutical Validation. The FDA is
coming!! The FDA is coming!! Howard Mark Mark Electronics, 21 Terrace Avenue, Suffern, NY 10901, USA.
Volume 13 Issue 2 Pages 14–14 (2002)
doi: 10.1255/nirn.659 Pharmaceutical Validation. Process
analytical technologies James K. Drennen III Associate Professor of Pharmaceutics and Head, Pharamaceutical Sciences Division, School of Pharmacy,
Duquesne University, Pittsburgh, PA 15282, USA. E-mail: drennen@duq.edu
Volume 13 Issue 1 Pages 12–13 (2002)
doi: 10.1255/nirn.648 Pharmaceutical NIR spectroscopy: a
state of enthusiastic anticipation Gary E. Ritchie Chairman, NIRVWoG, (Near Infrared Validation Working Group) Purdue Pharma L.P. (IR&D), Ardsley,
NY 10502, USA. E-mail: Gary.Ritchie@Pharma.com
Volume 12 Issue 6 Pages 10–13 (2001)
doi: 10.1255/nirn.640 Pharmaceutical Validation. Proving
the specificity of your NIR method James K. Drennen III, Associate Professor of Pharmaceutics and Head Pharmaceutical Sciences Division, School of
Pharmacy, Duquesne University, Pittsburgh, PA 15282, USA. E-mail: drennen@duq.edu
Volume 12 Issue 5 Pages 13–13 (2001)
doi: 10.1255/nirn.632 Pharmaceutical Validation. Proposed
<1119> Revision James K. Drennen III, Associated Professor of Pharmaceuticals and Head Pharmaceutical Sciences Division, Duquesne University,
Pittsburgh, PA 15282, USA. E-mail: drennen@duq.edu
Volume 12 Issue 4 Pages 7–13 (2001)
doi: 10.1255/nirn.623 Pharmaceutical Validation. The
PASG validation guidelines for NIR methods in the pharmaceutical industry Ken Prebble Pharmaceutical Analytical Sciences Group, NIR Sub-Group,
UK
Volume 12 Issue 2 Pages 5–6 (2001)
doi: 10.1255/nirn.604 Pharmaceutical Validation Column James K. Drennen III, Associate Professor of Pharmaceutics and Head Pharmaceutical Sciences Division, School of Pharmacy, Duquesne University,
Pittsburgh, PA 15282, USA. E-mail: drennen@duq.edu
|